CymaBay Therapeutics, Inc.

Report date
12/31/2023
Quarter
2023 Q4
Filed
2/14/2024
Shares
1,967,858
Value ($000)
46,481
Weight
0.3%
2023 Q3 - 2023 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).